Latest Regurgitation Stories
Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., April 13, 2015 /PRNewswire/ -- Tendyne Holdings,
FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015 SAN DIEGO, March 15, 2015 /PRNewswire/ -- About three
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 /PRNewswire/
LUXEMBOURG, December 29, 2014 /PRNewswire/ -- Boulle Medtech Ltd, a Jean Boulle Group company focusing on medical technology and a founding investor of Tendyne Holdings,
ROSEVILLE, Minn., Dec. 15, 2014 /PRNewswire/ -- Tendyne Holdings, Inc.
LUXEMBOURG, December 10, 2014 /PRNewswire/ -- Boulle Medtech Ltd., a Jean Boulle Group private company focusing on medical technology, and founding investor of Tendyne
ROSEVILLE, Minn., Dec. 2, 2014 /PRNewswire/ -- Tendyne Holdings, Inc.
Allegheny General Hospital, part of the Allegheny Health Network, is offering a new, minimally-invasive procedure that enables physicians to repair a damaged mitral valve as the heart continues
Funds to Be Used to Extend Commercial Efforts, Capitalize on Promising Patient Data KIRKLAND, Wash., Oct.
Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc.
- The parings of haberdine; also, any kind of fragments.